Janus Henderson Group’s Processa Pharmaceuticals PCSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$29.5M Buy
+18,016
New +$38.7K 0.01% 541

Other funds holding PCSA

Janus Henderson Group's PCSA Position: Q3 2026 in Review

Janus Henderson Group opened a new position in Processa Pharmaceuticals (PCSA) in Q3 2026: 18,016 shares worth $29.5M. The stake represents 0.01% of the portfolio and ranks #541 among its holdings.

18 funds tracked by Wall St. Rank hold PCSA as of Q3 2026.

  • Janus Henderson Group held 18,016 shares of Processa Pharmaceuticals worth $29.5M as of Q3 2026.
  • Processa Pharmaceuticals was a new Janus Henderson Group position in Q3 2026.
  • Processa Pharmaceuticals made up 0.01% of Janus Henderson Group's portfolio in Q3 2026, its #541 holding.
  • 18 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q3 2026.

Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.